Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dopamine receptors located within the mesolimbic pathway, a key dopaminergic circuit in the brain. These receptors, primarily G protein-coupled receptors, mediate the effects of dopamine, a neurotransmitter crucial for reward, motivation, and reinforcement learning. The main subtypes expressed in this region are D1-like (D1, D5) and D2-like (D2, D3, D4) dopamine receptors. Dysregulation or abnormal signaling through these receptors/pathways is implicated in addiction, schizophrenia, ADHD, depression, and chronic pain.
Agonism, antagonism, or modulation of dopamine receptor signaling in the mesolimbic pathway.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine Receptor (Mesolimbic) (N/A).